Data through FY2026 Q3 (Jun 30, 2026)
BioMarin Pharmaceutical Inc.
Company profile for BioMarin Pharmaceutical Inc. covers 65 filings across the reporting window. FY2026 certified median offer: $141,898.
- FY2026 certified median
- $141,898
- Total filings
- 65
- FY2026 25th–75th percentile
- $114,275–$149,261
- Top job title
- Scientist 1, Gene Therapy Research
| Fiscal year | Filings | Median | 25th percentile | 75th percentile |
|---|---|---|---|---|
| FY2024 | 24 | $110,854 | $108,399 | $129,168 |
| FY2025 | 34 | $131,560 | $111,723 | $155,485 |
| FY2026 (Q1–Q3) | 7 | $141,898 | $114,275 | $149,261 |
FY2026 is partial (*). Its filing totals are not comparable to a full fiscal year.
Median offer by fiscal year
Top titles
- Scientist 1, Gene Therapy Research3 filings
- Associate Director, Global Process Leader - Forecast to Plan2 filings
- Sr. Business Systems Analysis Manager2 filings
- Sr. Manager, Commercial CFIT Solutions Delivery2 filings
- Sr. Manager, In Vivo Lead, Hematology Research2 filings
- Sr. Research Associate 1, Tech Ops2 filings
- Associate 1, Research and Early Development Outsourcing1 filings
- Associate Director, Clinical Supply Chain Planning1 filings
- ASSOCIATE DIRECTOR, INFORMATION TECHNOLOGY1 filings
- Associate Director, Sales Analytics1 filings
Top cities
- San Rafael30 filings
- Novato21 filings
- Petaluma2 filings
- Chicago2 filings
- Brisbane1 filings
- Folsom1 filings
- Pomona1 filings
- Rancho Cordova1 filings
- West Hills1 filings
- Sugar Hill1 filings